ATH
Click for more information
12.5% 0.5¢ alterity therapeutics limited

This ann. shows that they are funding Parkinsons research as...

  1. gumboot
    383 Posts.
    lightbulb Created with Sketch. 19
    clock Created with Sketch.
    04/11/21
    14:02
    Post #: 57315992
    This ann. shows that they are funding Parkinsons research as well as proceeding with the MSA trial.
    They don't say much, but this is interesting. Parkinsons is obviously a much larger concern in medicine
    ATH Price at posting: 3.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
0.001(12.5%) 		Mkt cap ! $23.60M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $1.603K 341.6K

Buyers (Bids)

No. Vol. Price($)
60 68910222 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 29034580 23
View Market Depth
Last trade - 15.59pm 04/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.